Thermo Fisher Scientific Strengthens Bioproduction Offering by Acquiring Advanced Scientifics, Inc.

Thursday, February 5, 2015 7:30 am EST

Dateline:

WALTHAM, Mass.

Public Company Information:

NYSE:
TMO
"We see this acquisition as a great opportunity to meet customer demand for quality and productivity in bioprocessing, and plan to leverage our global reach to bring these innovative products to a larger customer base."

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has acquired Advanced Scientifics, Inc. (ASI), a global provider of single-use technologies for customized bioprocessing solutions, for $300 million in cash.

ASI designs, manufactures and delivers customized single-use systems and equipment for the preparation, processing, storage and transportation of biopharmaceuticals. The company has 380 employees and operations in Pennsylvania and Mexico.

“ASI’s intense customer focus has led to the development of innovative solutions that complement our existing single-use technologies and expand our offering across the bioprocessing workflow,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “We see this acquisition as a great opportunity to meet customer demand for quality and productivity in bioprocessing, and plan to leverage our global reach to bring these innovative products to a larger customer base.”

Advanced Scientifics had approximately $80 million in 2014 revenue and will be integrated into Thermo Fisher’s Life Sciences Solutions Segment. The company expects accretion to its adjusted earnings per share from the acquisition to be immaterial.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Contact:

Thermo Fisher Scientific Inc.
Media Contact Information:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com
or
Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

Thermo Fisher Tweets

https://t.co/bNuZc6eWML-14 hours 16 min ago
NEW CRISPR Libraries: advancing high throughput screening. https://t.co/PXSsbmsFbP https://t.co/DQfhzejLUg-15 hours 2 min ago
Don’t lose precious samples! For secure protein dialysis, learn more: https://t.co/rnaOxeo7zt https://t.co/77WRZ5Sqqv-18 hours 2 min ago
The Mad Dash to Japan by : how favorable regulations are impacting cell therapy clinical trials https://t.co/rZ3xIRHUg0-20 hours 55 sec ago
Forensic DNA analysis- what do you do next when there is no STR match in the database? https://t.co/0JueZAWuE5-1 day 10 hours ago